Cargando…
Short-Term ONX-0914 Administration: Performance and Muscle Phenotype in Mdx Mice
Duchenne muscular dystrophy (DMD) is a severe muscle-wasting disease. Although the lack of dystrophin protein is the primary defect responsible for the development of DMD, secondary disease complications such as persistent inflammation contribute greatly to the pathogenesis and the time-dependent pr...
Autores principales: | Kwak, Dongmin, Wei, Guoxian, Thompson, LaDora V., Kim, Jong-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399807/ https://www.ncbi.nlm.nih.gov/pubmed/32707682 http://dx.doi.org/10.3390/ijerph17145211 |
Ejemplares similares
-
The immunoproteasome‐specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis
por: Althof, Nadine, et al.
Publicado: (2018) -
ONX-0914 Induces Apoptosis and Autophagy with p53 Regulation in Human Glioblastoma Cells
por: Chang, Hsin-Han, et al.
Publicado: (2022) -
Immunoproteasome Activity and Content Determine Hematopoietic Cell Sensitivity to ONX-0914 and to the Infection of Cells with Lentiviruses
por: Vagapova, Elmira, et al.
Publicado: (2021) -
Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL–AF4 fusion protein
por: Jenkins, Tyler W., et al.
Publicado: (2021) -
Low Neurotoxicity of ONX-0914 Supports the Idea of Specific Immunoproteasome Inhibition as a Side-Effect-Limiting, Therapeutic Strategy
por: von Brzezinski, Laura, et al.
Publicado: (2017)